Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2017 1
2019 3
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R, Ludmir EB, Miccio JA, Menon H, Barsky AR, Mesko SM, Kodali M, Lautenschlaeger T, Adeberg S, Simone CB 2nd, Verma V. Patel R, et al. Among authors: mesko sm. Pract Radiat Oncol. 2020 Nov-Dec;10(6):423-433. doi: 10.1016/j.prro.2020.02.007. Epub 2020 Feb 20. Pract Radiat Oncol. 2020. PMID: 32088429 Review.
Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial.
Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE, Nguyen QN, McGuire SE, Pollack A, Anscher MS. Pasalic D, et al. Among authors: mesko sm. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):790-797. doi: 10.1016/j.ijrobp.2019.02.045. Epub 2019 Mar 2. Int J Radiat Oncol Biol Phys. 2019. PMID: 30836166 Free PMC article. Clinical Trial.
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.
Pasalic D, Lu Y, Betancourt-Cuellar SL, Taku N, Mesko SM, Bagley AF, Chance WW, Allen PK, Tang C, Antonoff MB, Balter PA, Mehran RJ, Welsh JW, Liao Z, Gomez D, Erasmus JJ, Nguyen QN. Pasalic D, et al. Among authors: mesko sm. Radiother Oncol. 2020 Apr;145:178-185. doi: 10.1016/j.radonc.2020.01.010. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044530
Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.
Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Ning MS, et al. Among authors: mesko sm. Brachytherapy. 2019 Jul-Aug;18(4):445-452. doi: 10.1016/j.brachy.2019.03.003. Epub 2019 Apr 13. Brachytherapy. 2019. PMID: 30992185